Dunamu & Partners, the investment arm of Dunamu, has made a follow-on investment in AIRS Medical, a Korean AI-powered medical imaging company. Dunamu & Partners first backed AIRS Medical in its Series C round in 2024, and its cumulative investment now totals $6.24M (KRW 9.7 billion). The latest round also drew participation from TA Associates, a global private equity firm managing $65 billion in assets.
AIRS Medical develops SwiftMR, an AI solution that cuts MRI scan times by up to 50% and upgrades low-quality MRI images into high-resolution scans, along with SwiftSight, a platform for MRI quantification and structured reporting. The company’s solutions are currently used by more than 1,700 medical institutions across over 40 countries, supporting more than 6 million AI-assisted scans annually.
With the new capital, AIRS Medical plans to expand its footprint in the US and European markets, extend its solutions further into clinical applications, and advance next-generation AI technology.
“We will focus on expanding our business in core markets like the US and Europe and developing next-generation AI technology to solidify our leadership in the global medical imaging AI category,” said Jangsoon Park, CEO of AIRS Medical.
MORE FROM THE POST
- TAPZERO Lands Kakao Ventures Seed Funding to Build Personal Digital Twin for Longevity
- Walk101 Secures Seed Funding and TIPS Selection for AI-Powered Musculoskeletal X-ray Analysis
- Neuble AI Raises $269K Seed Funding From Futureplay to Advance AI-Powered Brain Diagnostics
- Rosota Raises $965K Seed Round to Build AI-Native Surgical Robots
- INNOVAID Raises $7.8M Series B to Expand Dentlink Dental Lab Platform Into U.S. and Australia
Share
Most Read
- 1
- 2
- 3
- 4
- 5
Leave a Reply